FRAZIER MANAGEMENT LLC - SIERRA ONCOLOGY INC ownership

Quarter-by-quarter ownership
FRAZIER MANAGEMENT LLC ownership history of SIERRA ONCOLOGY INC
ValueSharesWeighting
Q2 2022$1,117,000
-36.2%
20,316
-62.8%
100.00%
+13.5%
Q1 2022$1,752,000
-93.6%
54,654
-95.7%
88.13%
+4062.9%
Q4 2021$27,498,000
+55.9%
1,264,861
+57.2%
2.12%
+50.0%
Q3 2021$17,638,000
+346.6%
804,667
+296.8%
1.41%
+287.6%
Q2 2021$3,949,000
+13.0%
202,8030.0%0.36%
+30.0%
Q1 2021$3,494,000
+7.5%
202,8030.0%0.28%
+12.0%
Q4 2020$3,251,000
+50.2%
202,8030.0%0.25%
+28.9%
Q3 2020$2,164,000
-11.8%
202,8030.0%0.19%
-9.8%
Q2 2020$2,454,000
+23.2%
202,8030.0%0.22%
-4.9%
Q1 2020$1,992,000202,8030.23%
Other shareholders
SIERRA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 643,959$10,323,0006.44%
Vivo Capital, LLC 1,917,074$30,731,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 135,000$2,164,0001.26%
Ghost Tree Capital, LLC 200,000$3,206,0000.71%
Telemetry Investments, L.L.C. 22,349$358,0000.60%
FRAZIER MANAGEMENT LLC 202,803$3,251,0000.25%
MANGROVE PARTNERS IM, LLC 108,914$1,746,0000.24%
Ikarian Capital, LLC 318,890$5,111,0000.22%
Sio Capital Management, LLC 66,455$1,065,0000.22%
Orbimed Advisors 1,477,320$23,681,0000.21%
View complete list of SIERRA ONCOLOGY INC shareholders